Effects of Phytochemicals on Type 2 Diabetes Via MicroRNAs

Overview

Journal Curr Nutr Rep

Specialty Nutritional Sciences

Date 2024 May 28

PMID 38805166

Authors

Dilek Sivri

Makbule Gezmen-Karadag

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Type 2 diabetes, characterized by inadequate insulin secretion and resistance, is increasingly prevalent. To effectively manage type 2 diabetes, identifying new therapeutic targets is crucial. MicroRNAs, short noncoding RNA molecules, play a pivotal role in regulating β-cell function, insulin production, and resistance, and show promise as biomarkers for predicting type 2 diabetes onset. Phytochemicals, known for their antioxidant activities, may influence microRNA expression, potentially improving insulin sensitivity and mitigating associated complications. This review aims to explore the significance of microRNA in type 2 diabetes, their potential as biomarkers, and how certain phytochemicals may modulate microRNA expressions to reduce or prevent diabetes and its complications.

Recent Findings: Current research suggests that microRNAs show promise as novel therapeutic biomarkers for diagnosing type 2 diabetes and monitoring diabetic complications. Additionally, phytochemicals may regulate microRNAs to control type 2 diabetes, presenting a potential therapeutic strategy. The multifactorial effects of phytochemicals on type 2 diabetes and its complications through microRNAs warrant further research to elucidate their mechanisms. Comprehensive clinical trials are needed to assess the safety and efficacy of phytochemicals and their combinations. Given their ability to modulate microRNAs expression, incorporating phytochemical-rich foods into the diet may be beneficial.

References

Wang L, Sun Y, Liu H, Yang X, Wen Z, Tian X . β-Sitosterol attenuates anlotinib resistance in non-small cell lung cancer cells by inhibiting miR-181a-3p/SHQ1 signaling. Chem Biol Drug Des. 2024; 103(3):e14493. DOI: 10.1111/cbdd.14493. View

Zhu H, Leung S . Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia. 2015; 58(5):900-11. DOI: 10.1007/s00125-015-3510-2. View

Chang W, Wen L, Zhang L, Tong X, Jin Y, Chen G . Association of rs2910164 in miR-146a with type 2 diabetes mellitus: A case-control and meta-analysis study. Front Endocrinol (Lausanne). 2022; 13:961635. PMC: 9551998. DOI: 10.3389/fendo.2022.961635. View

Qin N, Chen Y, Jin M, Zhang C, Qiao W, Yue X . Anti-obesity and anti-diabetic effects of flavonoid derivative (Fla-CN) via microRNA in high fat diet induced obesity mice. Eur J Pharm Sci. 2015; 82:52-63. DOI: 10.1016/j.ejps.2015.11.013. View

Wu H, Sheng Z, Xie J, Li R, Chen L, Li G . Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus. Oxid Med Cell Longev. 2016; 2016:9836860. PMC: 5090089. DOI: 10.1155/2016/9836860. View

Kappeler L . Role of Adipose Tissue microRNAs in the Onset of Metabolic Diseases and Implications in the Context of the DOHaD. Cells. 2022; 11(23). PMC: 9739499. DOI: 10.3390/cells11233711. View

Bastos R, Dorna M, Chiuso-Minicucci F, Felix T, Fernandes A, Azevedo P . Acute green tea intake attenuates circulating microRNA expression induced by a high-fat, high-saturated meal in obese women: A randomized crossover study. J Nutr Biochem. 2022; 112:109203. DOI: 10.1016/j.jnutbio.2022.109203. View

Ramirez-Alarcon K, Victoriano M, Mardones L, Villagran M, Al-Harrasi A, Al-Rawahi A . Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2021; 12:656978. PMC: 8204854. DOI: 10.3389/fendo.2021.656978. View

Xu F, Liu Y, Zhu X, Li S, Shi X, Li Z . Protective Effects and Mechanisms of Vaccarin on Vascular Endothelial Dysfunction in Diabetic Angiopathy. Int J Mol Sci. 2019; 20(18). PMC: 6769517. DOI: 10.3390/ijms20184587. View

10.

Liu H, Wang L, Li F, Jiang Y, Guan H, Wang D . The synergistic protection of EGCG and quercetin against streptozotocin (STZ)-induced NIT-1 pancreatic β cell damage via upregulation of BCL-2 expression by miR-16-5p. J Nutr Biochem. 2021; 96:108748. DOI: 10.1016/j.jnutbio.2021.108748. View

11.

Xiao D, Zhou T, Fu Y, Wang R, Zhang H, Li M . MicroRNA-17 impairs glucose metabolism in insulin-resistant skeletal muscle via repressing glucose transporter 4 expression. Eur J Pharmacol. 2018; 838:170-176. DOI: 10.1016/j.ejphar.2018.08.036. View

12.

Kumar A, P N, Kumar M, Jose A, Tomer V, Oz E . Major Phytochemicals: Recent Advances in Health Benefits and Extraction Method. Molecules. 2023; 28(2). PMC: 9862941. DOI: 10.3390/molecules28020887. View

13.

Wei S, Zhang M, Yu Y, Lan X, Yao F, Yan X . Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway. PLoS One. 2016; 11(3):e0152097. PMC: 4806913. DOI: 10.1371/journal.pone.0152097. View

14.

Chi T, Lin J, Wang M, Zhao Y, Liao Z, Wei P . Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management. Front Endocrinol (Lausanne). 2021; 12:630032. PMC: 8484715. DOI: 10.3389/fendo.2021.630032. View

15.

Yu C, Yang C, Rui Z . MicroRNA-125b-5p improves pancreatic β-cell function through inhibiting JNK signaling pathway by targeting DACT1 in mice with type 2 diabetes mellitus. Life Sci. 2019; 224:67-75. DOI: 10.1016/j.lfs.2019.01.031. View

16.

Flowers E, Aouizerat B, Abbasi F, Lamendola C, Grove K, Fukuoka Y . Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention. Metabolism. 2015; 64(9):1051-9. PMC: 4546550. DOI: 10.1016/j.metabol.2015.05.013. View

17.

Elseweidy M, Elawady A, Sobh M, Alqhtani A, Al-Gabri N, Elnagar G . Potential of Caffeic Acid and 10-Dehydrogingerdione as Lipid Regulators Relevant to Their Inhibitory Effect on miR-122 and ATP Citrate Lyase Activity in Diabetic Hyperlipidemic Rats. Biomedicines. 2023; 11(3). PMC: 10045664. DOI: 10.3390/biomedicines11030726. View

18.

Jimenez-Lucena R, Camargo A, Alcala-Diaz J, Romero-Baldonado C, Luque R, van Ommen B . A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Exp Mol Med. 2019; 50(12):1-12. PMC: 6312530. DOI: 10.1038/s12276-018-0194-y. View

19.

Formichi C, Fignani D, Nigi L, Grieco G, Brusco N, Licata G . Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study. Int J Mol Sci. 2021; 22(17). PMC: 8431190. DOI: 10.3390/ijms22179454. View

20.

Ding X, Gu T, Wang W, Song L, Chen T, Xue Q . Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206. Mol Nutr Food Res. 2015; 59(12):2355-70. DOI: 10.1002/mnfr.201500370. View